新規ピリミドン誘導体 - ORCHID CHEMICALS & PHARMACEUTICALS LIMITED

Title:

新規ピリミドン誘導体

Document Type and Number:

Japanese Patent JP2005535570

Kind Code:

A

Abstract:

The present invention relates to novel amino substituted pyrimidinone derivatives of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel amino substituted pyrimidinone derivatives of the general formula (I) and a method thereof.

More Like This:

JP2023520976	2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazoline- Pharmaceutical composition containing 4-yl]acetate and sodium ion
JP6335188	Protein SLURP-1 for use in the treatment of eye diseases
WO/2019/242039	METHOD FOR PREPARING ROCURONIUM BROMIDE INJECTION WITH LOW IMPURITY LEVEL

Inventors:

Shiv, Kumar, Agarwol
Ravi Kumar, Tadi Parthi
Pawan, Agarwol
Savitiri, Shiva Kumar
Devendranus, Day
Biswazi, nag

Application Number:

JP2003582135A

Publication Date:

November 24, 2005

Filing Date:

April 10, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ORCHID CHEMICALS & PHARMACEUTICALS LIMITED

International Classes:

A61K9/08; A61K9/10; A61K9/14; A61K9/20; A61K9/48; A61K31/513; A61P1/04; A61P1/18; A61P3/10; A61P7/00; A61P9/10; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/08; A61P19/10; A61P21/00; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/12; A61P31/16; A61P31/18; A61P31/22; A61P33/06; A61P35/00; A61P35/02; A61P37/00; A61P37/06; A61P37/08; A61P39/02; C07C69/738; C07C257/18; C07C317/44; C07C317/48; C07C317/50; C07D239/46; C07C323/32; C07C323/42; C07C323/44; C07C323/62; C07C327/48; C07C327/58; C07D239/36; C07D239/48; C07D239/54; C07D239/56; C07D265/06; (IPC1-7): C07D239/46; A61K9/08; A61K9/10; A61K9/14; A61K9/20; A61K9/48; A61K31/513; A61P1/04; A61P1/18; A61P3/10; A61P7/00; A61P9/10; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/08; A61P19/10; A61P21/00; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/12; A61P31/16; A61P31/18; A61P31/22; A61P33/06; A61P35/00; A61P35/02; A61P37/06; A61P37/08; A61P39/02; C07C317/44; C07C323/32; C07C323/62; C07C327/48

Attorney, Agent or Firm:

Kenji Yoshitake
Yukitaka Nakamura
Konno Akio
Noritaka Yokota

Previous Patent: ＧＬＰ−１アゴニスト及び心臓血管合併症

Next Patent: 抗イディオタイプ抗ＣＥＡ抗体分子および癌ワクチンとしてのその使用